AFLAC Incorporated vs Alcon AG — how do they compare? AFLAC Incorporated trades at $121.06 (market cap $60.70B), while Alcon AG trades at $72.48 (market cap $36.44B). The key difference: AFLAC Incorporated is the larger of the two by market cap, and AFLAC Incorporated pays the higher dividend (2.02%). Which is the better fit depends on your goals.
| AFL | ALC | |
|---|---|---|
Market Cap | $60.70B | $36.44B |
Sector | Financials | Health |
52-Week High | $129.55 | $90.12 |
52-Week Low | $103.55 | $62.02 |
Enterprise Value | $70.65B | $40.28B |
Dividend Yield | 2.02% | 0.48% |
Trailing returns across standard periods
Latest headlines on both assets
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →